cancer2023Japan
 

Online Registration

Hosting Organization

World High Technology Society

Overseas Cooperate Medias and Journals

Program Layout


                          

  Cancer (WCC-2023) 

      

Final Program


           

Cluster Meeting List:  
      
► The 13th Annual Conference Neurotalk (NT)
► The 6th Annual World Congress of Oral & Dental Medicine (CODM)
► The 8th Annual World Congress of Infectious Diseases (WCID)
► World Biotechnology Industry Conference
► The 13th Annual International Congress of Cardiology (ICC)

 

 Registration

Time: 09:00-21:00, November 14, 2023 (Tuesday); Place: Lobby, 1F, Hotel emisia Sapporo

 

Opening Ceremony

Time: 09:00-09:15, November 15, 2023 (Wednesday); Place: Pastel, 2F, Hotel emisia Sapporo

 

Keynote Forum

Time: 09:15-12:00, November 15, 2023 (Wednesday); Place: Pastel, 2F, Hotel emisia Sapporo

 

09:15-09:20

Moderator’s Introduction

09:20-09:40

Title: Maritime Security in the Age of Climate Change

Dr. Peter Ricketts, President and Vice-Chancellor, Acadia University, Canada

09:40-10:00

Title: TBD

Dr. Amir M. Sharif, Dean of the Faculty of Management and Professor, University of Bradford, UK

10:00-10:20

Title: Integrating Artificial Intelligence with Computational Fluid Dynamics to Optimize And Sustain Urban Water Management and Treatment

Dr. John Sansalone, Professor, Engineering School of Sustainable Infrastructure and Environment, University of Florida, USA

10:20-10:40

Title: Does Higher Education Promote Social Mobility?

Dr. Hiroshi Ishida, Professor University of Tokyo, Japan

10:40-11:00

Title: Eradicating World Illiteracy through Web-Based Intelligent Reading and Writing Systems

Dr. Kausalai (Kay) Wijekumar, Houston Endowed Chair, Texas A&M University, USA

11:00-11:20

Title: CTGF in Pancreatic Cancer

Dr. Ewa Carrier, Vice President, Clinical Development, Fibrogen, USA

11:20-11:40 Title: New Explores for Alzheimer’s Therapeutics
Dr. Ying Xia, Professor, Fudan University, China

11:40-12:00

Title: The Novel Biodetection Technology Using Peptide-microarrays Based on the Novel Principles, Independent of Marker-molecules, and Their Applications
Dr. Kiyoshi Nokihara, Founder & CEO/CSO, HiPep Laboratories, Japan; The First School of Clinical Medicine, The First Affiliated Hospital with Nanjing Medical University, China

 


WCC 01: Cancer Basic Research & Diagnosis

Time: 13:30-16:45, November 15, 2023 (Wednesday); Place: Symphony C, 4F, Hotel emisia Sapporo

Topic: Cancer Genetics, Genomics and Epigenetics, Cancer Cell Metabolism, Tumor Microenvironment

Chair

Dr. Kiyoshi Nokihara, Founder & CEO/CSO, HiPep Laboratories, Japan; The First School of Clinical Medicine, The First Affiliated Hospital with Nanjing Medical University, China

Co-Chair

Dr. Jun Wan, Director & Associate Professor, Indiana University School of Medicine, USA

 

13:30-13:35

Chair’s Introducition

13:35-14:00

Keynote Speech
Title:
"Programmable" and "Intelligent" Vectors for New Clinical Applications of Gene Therapy
Dr. Farzin Farzaneh, Professor, King's College London, UK; Chief Scientific Officer, ViroCell Biologics, UK

14:00-14:25

Title: Using Polygenic Risk Scores to Improve Screening for Pancreatic Cancer

Dr. Andrew R. Collins, Professor, University of Southampton, Southampton General Hospital, UK

14:25-14:50

Title: Principles of A Novel Biochip and Applications to Gastric Cancer Risk Determination

Dr. Kiyoshi Nokihara, Founder & CEO/CSO, HiPep Laboratories, Japan; The First School of Clinical Medicine, The First Affiliated Hospital with Nanjing Medical University, China

14:50-15:15

Title: Identification of Novel Marker Genes for Neuroendocrine Prostate Cancer (NEPC)

Dr. Jun Wan, Director  & Associate Professor, Indiana University School of Medicine, USA

15:15-15:30

Coffee Break

15:30-15:55

Title: Longitudinal Tumor Marker Models to Improve Clinical Follow-up and Predict Non-response to Treatment; Lessons Learned from Lung Cancer

Dr. Huub H. van Rossum, Specialist in Laboratory Medicine, Netherlands Cancer Institute, the Netherlands

15:55-16:20

Title: Cellular Acetyl-CoA Deficiency Slows down Colorectal Cancer Progression

Dr. Yan Chun Li, Associate Professor, Univesity of Chicago, USA

16:20-16:45

Title: T cell Antigen Recognition in Cancer Immunotherapy

Dr. Jun Huang, Tenured Professor, University of Chicago, USA

 

 

WCC 02: Clinical Oncology 

Time: 08:30-10:15, November 16, 2023 (Thursday); Place: Azalea, 4F, Hotel emisia Sapporo

Topic: Head, Neck, Brain Cancers, and CNS Tumors; Lung Cancer / Other Thoracic Cancers; Digestive System Cancers; Hematological Malignancies

Chair

Dr. Allen M Chen, Professor, University of California, Irvine, USA

Co-Chair

Dr. Christopher Poremba, Professor of Pathology and Molecular Pathology, Institute of Pathology of the Technical University of Munich, Germany

 

08:30-08:35

Chair’s Introducition

08:35-08:55

Title: Evolving Paradigms in Human Papillomavirus-Positive Oropharyngeal Cancer

Dr. Allen M Chen, Professor, University of California, Irvine, USA

08:55-09:15

Title: Efficacy and Safety of Endoscopic “Calabash” Ligation and Resection for Small Gastric Stromal Tumors Originating from the Muscularis Propria

Dr. Zhenglei Xu, Associate Professor, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, China

09:15-09:35

Title: An Effective Approach Using Ensemble Learning Based on A Random Subspace Method in Laser-Induced Breakdown Spectroscopy to Diagnose Blood Cancer

Dr. Qi Jianwei, Associate Professor, Chinese Academy of Medical Sciences (Institute of Hematology), China

09:35-09:55

Title: Clinic Date Update on A Bispecific Antibody PDL1/VEGF for the Treatment of Kidney Cancers

Dr. Xiangyang Zhu, CEO, Huaota Biopharm, China

09:55-10:15

Title: The Clinical Significance of Prophylactic Lymph Node Dissection in Thyroid Cancer

Dr. Shih Ming Huang, National Cheng Kung University, Taiwan, China

 

 

WCC 03: Cancer Therapies

Time: 13:30-17:10, November 16, 2023 (Thursday); Place: Symphony C, 4F, Hotel emisia Sapporo

Topic: Cancer Immunotherapy; Cancer Personalized Therapy and Combination Therapy; Robotic & Surgical Therapy; Cancer Stem Cell Therapy

Chair

Dr. Mustaqeem Siddiqui, Consultant in Hematology, Mayo Clinic International, USA

Co-Chair

Dr. Ewa Carrier, Vice President, Clinical Development, Fibrogen, USA

 

13:30-13:35

Chair’s Introducition

13:35-13:55

Title: Impact of Immunotherapeutic Administration on the Mediastinal Fat-associated Lymphoid Clusters and Lung Tissue in Healthy Mice

Dr. Yaser Elewa, Tenured Assistant Professor, Hokkaido University, Japan

13:55-14:15

Title: Cancer-associated Thrombosis and Its Treatment

Dr. Tatiana Byzova, Professor & Director, Angiogenesis Center, Lerner Research Institute, Cleveland Clinic, USA

14:15-14:35

Title: The Promise of Cancer Immunotherapy – from Monclonal, Bispecific, and Trispecifics to CART Therapy

Dr. Mustaqeem Siddiqui, Consultant in Hematology, Mayo Clinic International, USA

14:35-14:55

Title: Results from A Phase II Study of Gemcitabine/Nab-paclitaxel with Pamrevlumab: A Novel Drug Combination for the Treatment of Locally Advanced Pancreatic Cancer (LAPC)

Dr. Ewa Carrier, Vice President, Clinical Development, Fibrogen, USA

14:55-15:15

Title: Radiation Recall Reactions: An Oncologic Enigma

Prof. Michael J. McKay, Senior Specialist & Professor, Northwest Regional Hospital; University of Tasmania, Australia

 

 

WCC 04: Anti-Cancer Drug Discovery and Development

Time: 08:30-10:15, November 17, 2023 (Friday); Place: Symphony B, 4F, Hotel emisia Sapporo

Topic: Anti-cancer Drug Delivery; Anticancer Drugs from TCM and Natural Products; New Cancer Drugs Discovery  

Chair

Dr. Y. George Zheng, Professor, University of Georgia, USA

Co-Chair Dr. Sumith A Kularatne, Executive Vice President, Research & Development, On Target Laboratories, USA

 

08:30-08:35

Chair’s Introducition

08:35-09:00

Keynote Speech

Title: Tumor-Specific Imaging, Diagnosis, and Therapy for Cancer

Dr. Sumith A Kularatne, Executive Vice President, Research & Development, On Target Laboratories, USA

09:00-09:25

Title: Discovery and Development of A First-in-class Small Molecule Degrader Targeting Cell Cycle Regulators

Ms. So Young Yoon, BD Manager, Aevis Bio, Inc., USA

09:25-09:50

Title: Pharmacophore-Based Design of Small Molecule Inhibitors of Protein Arginine Methyltransferases for Cancer Therapy

Dr. Y. George Zheng, Professor, University of Georgia, USA

09:50-10:15

Title: A Functional Zinc Finger Transcription Factor Degrader

Dr. Bee Hui Liu, National University of Singapore, Singapore

 

WCC 05: Video Forum

 

1

Title: interventional Oncology in Lung Cancer New Techniques on Local Chemotherapy and Ablation

Dr. Thomas J. Vogl, Professor, University Frankfurt, Germany

2

Title: Thymic Carcinoma Treated by CyberKnife

Dr. Yuko Harada, Vice Director of Cardiology, Kawasaki Municipal Ida Hospital, Japan

 

 

Hosting Organization

Official Travel Agency

 

Media

Partners

Contact Us

Add: Life Science Innovation Center BLD 3-2, 43 Torch Road,
High Tech Park, Dalian, LN 116023, China

© 2003-2023 All rights reserved by BIT Congress